These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3964818)

  • 1. Binding and activation of hemolytic complement by IgG antibodies: cooperativity between antibodies of different hapten specificity.
    Borsos T; Circolo A
    J Immunol; 1985 Jan; 134(1):492-4. PubMed ID: 3964818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis of hapten-labeled cells by anti-hapten IgG and complement: effect of cell surface hapten density.
    Circolo A; Borsos T
    J Immunol; 1982 Mar; 128(3):1118-21. PubMed ID: 7057033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding and activation of C1 by cell bound IgG: activation depends on cell surface hapten density.
    Borsos T; Circolo A
    Mol Immunol; 1983 Apr; 20(4):433-8. PubMed ID: 6865957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.
    Füst G; Medgyesi GA; Rajnavölgyi E; Csécsi-Nagy M; Czikora K; Gergely J
    Immunology; 1978 Dec; 35(6):873-84. PubMed ID: 104923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effect of concanavalin A on the hemolytic activity of anti-Forssman IgG: the role of C1.
    Langone JJ; Sandor M; Ejzemberg R
    J Immunol; 1982 Sep; 129(3):1159-64. PubMed ID: 7108204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of activation of complement by anti-hapten antibodies at the red cell surface: effect of patchy vs random distribution of hapten.
    Circolo A; Battista P; Borsos T
    Mol Immunol; 1985 Mar; 22(3):207-14. PubMed ID: 4000125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of hemolytic complement by mouse monoclonal IgG1 antibody: comparison with rabbit IgG.
    Battista P; Circolo A; Borsos T
    Mol Immunol; 1985 Mar; 22(3):215-21. PubMed ID: 2582242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic efficiency of cell-bound IgM: evidence that IgM-C1 complexes activate C4 molecules not hemolytic with homologous C2--C9.
    Ejzemberg R; Borsos T
    J Immunol; 1982 Apr; 128(4):1600-2. PubMed ID: 7061844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex.
    Goers JW; Ziccardi RJ; Schumaker VN; Glovsky MM
    J Immunol; 1977 Jun; 118(6):2182-91. PubMed ID: 559020
    [No Abstract]   [Full Text] [Related]  

  • 11. The mechanism of synergistic complement-mediated lysis of rat red cells by monoclonal IgG antibodies.
    Hughes-Jones NC; Gorick BD; Howard JC
    Eur J Immunol; 1983 Aug; 13(8):635-41. PubMed ID: 6603980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse monoclonal antibodies at the red cell surface--II. Effect of hapten density on complement fixation and activation.
    Kratz HJ; Borsos T; Isliker H
    Mol Immunol; 1985 Mar; 22(3):229-35. PubMed ID: 4000127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hapten IgG antibodies bound to cell surface hapten: anti-IgG antibody prevents dissociation as measured with fluid phase hapten.
    Borsos T; Circolo A; Young-Cooper GO; Mage R
    J Immunol; 1986 Jan; 136(1):224-9. PubMed ID: 3079609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic modulation of the cytophilic binding of guinea-pig IgG and IgM antibodies to homologous macrophages.
    Webster RO; Lawrence DA
    Immunology; 1979 Apr; 36(4):659-70. PubMed ID: 86509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of hemolytic efficiency of anti-hapten IgG antibody by anti-IgG antibody is primarily the function of the anti-hapten IgG.
    Kirschfink M; Borsos T
    Mol Immunol; 1987 Mar; 24(3):253-7. PubMed ID: 3497338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the interaction between protein A and immunoglobulin G. I. Effect of protein A on the functional activity of IgG.
    Langone JJ; Boyle MD; Borsos T
    J Immunol; 1978 Jul; 121(1):327-32. PubMed ID: 353195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative binding of a complement component to antigen-antibody complexes. III. Complexes containing IgM antibodies.
    Kuo CY; Thompson JJ; Hoffmann LG
    Z Immunitatsforsch Immunobiol; 1976 Sep; 152(2):151-66. PubMed ID: 960974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation is not required for IgG-mediated suppression of the antibody response.
    Heyman B; Wiersma E; Nose M
    Eur J Immunol; 1988 Nov; 18(11):1739-43. PubMed ID: 3060362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.